Apixaban after acute coronary syndrome in patients with heart failure: insights from the APPRAISE-2 trial

被引：0
|
作者：
Cornel, J. [1 ]
James, S. [2 ]
Lopes, R. D. [3 ]
Mohan, P. [4 ]
Neely, M. [3 ]
Amerena, J. [5 ]
Huo, Y. [6 ]
Alexander, J. H. [3 ]
Harrington, R. A. [3 ]
Wallentin, L. [2 ]
机构：
[1] Med Ctr Alkmaar, Alkmaar, Netherlands
[2] Uppsala Univ, UCR Uppsala Clin Res Ctr, Uppsala, Sweden
[3] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC 27706 USA
[4] Bristol Myers Squibb Co, Princeton, NJ USA
[5] Barwon Hlth, Geelong, Vic, Australia
[6] Peking Univ, Hosp 1, Beijing 100871, Peoples R China
来源：
EUROPEAN HEART JOURNAL | 2012年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：335 / 336
页数：2
相关论文
共 50 条
  • [21] The prevalence of heart failure after acute coronary syndrome in patients with nonobstructive coronary atherosclerosis
    Gomboeva, S. B.
    Ryabov, V. V.
    Baev, A. E.
    Rogovskaya, Y. U. V.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 121 - 122
  • [22] Efficacy and safety of ticagrelor in patients with acute coronary syndrome and heart failure - insights from the platelet inhibition and patient outcomes (PLATO) trial
    Brito, F. S. B. De Souza
    Akerblom, A. A.
    Wojdyla, D. W.
    Steg, P. G. S.
    Wallentin, L. W.
    James, S. K. J.
    Katus, H. A. K.
    Himmelmann, A. H.
    Becker, R. C. B.
    Lopes, R. D. L.
    EUROPEAN HEART JOURNAL, 2014, 35 : 202 - 203
  • [23] Early biomarkers of acute kidney failure after heart angiography or heart surgery in patients with acute coronary syndrome or acute heart failure
    Torregrosa, Isidro
    Montoliu, Carmina
    Urios, Amparo
    Elmlili, Nisrin
    Juan, Isabel
    Jesus Puchades, M.
    Solis, Miguel A.
    Sanjuan, Rafael
    Luisa Blasco, M.
    Ramos, Carmen
    Tomas, Patricia
    Ribes, Jose
    Carratala, Arturo
    Miguel, Alfonso
    NEFROLOGIA, 2012, 32 (01): : 44 - 52
  • [24] Ticagrelor in patients with heart failure after acute coronary syndromes-Insights from the PLATelet inhibition and patient Outcomes (PLATO) trial
    Akerblom, Axel
    Wojdyla, Daniel M.
    Wallentin, Lars
    James, Stefan K.
    Brito, Flavio de Souza
    Steg, Philippe Gabriel
    Cannon, Christopher P.
    Katus, Hugo A.
    Himmelmann, Anders
    Storey, Robert F.
    Becker, Richard C.
    Lopes, Renato D.
    AMERICAN HEART JOURNAL, 2019, 213 : 57 - 65
  • [25] Burden of heart failure after an acute coronary syndrome in patients with diabetes mellitus
    Alberto Cordero, A.
    Rodriguez-Manero, M.
    Agra-Bermejo, M.
    Garcia-Acuna, J. M.
    Escribano, D.
    Bertomeu-Gonzalez, V.
    Moreno-Arribas, J.
    Alvarez, B.
    Baluja, A.
    Flores, E.
    Zuazola, P.
    Gonzalez-Juanatey, J. R.
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 342 - 342
  • [26] Prognosticators of heart failure in patients after treatment because of acute coronary syndrome
    Kotlar, I.
    Vavlukis, M.
    Pocesta, B.
    Krstevski, G.
    Taravari, H.
    Shehu, E.
    Kitanoski, D.
    Bojovski, I.
    Taneski, F.
    Kedev, S.
    EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 : 40 - 40
  • [27] Hospitalization Among Patients With Atrial Fibrillation and a Recent Acute Coronary Syndrome or Percutaneous Coronary Intervention Treated With Apixaban or Aspirin Insights From the AUGUSTUS Trial
    Vora, Amit N.
    Alexander, John H.
    Wojdyla, Daniel M.
    Aronson, Ronald
    Granger, Christopher B.
    Darius, Harald
    Windecker, Stephan
    Mehran, Roxana
    Averkov, Oleg
    Budaj, Andrzej
    Kong, David F.
    Kobalava, Zhanna
    Mehta, Rajendra H.
    Mirza, Zulfiqar
    Guimaraes, Patricia Oliveira
    Parkhomenko, Alexander
    Quadros, Alexandre
    Thiele, Holger
    Goodman, Shaun G.
    Lopes, Renato D.
    CIRCULATION, 2019, 140 (23) : 1960 - 1963
  • [28] Reduced versus Standard Dose Apixaban in Patients With Atrial Fibrillation and Acute Coronary Syndrome and/or Undergoing Percutaneous Coronary Intervention: Insights From the AUGUSTUS Trial
    Fudim, Marat
    Lopes, Renato D.
    Wojdyla, Daniel M.
    Mehran, Roxana
    Khan, Mohammad S.
    Granger, Christopher B.
    Goodman, Shaun G.
    Aronson, Ron
    Windecker, Stephan
    Alexander, John H.
    CIRCULATION, 2022, 146
  • [29] Apixaban or Vitamin K Antagonists and Aspirin or Placebo According to Kidney Function in Patients With Atrial Fibrillation After Acute Coronary Syndrome or Percutaneous Coronary Intervention Insights From the AUGUSTUS Trial
    Hijazi, Ziad
    Alexander, John H.
    Li, Zhuokai
    Wojdyla, Daniel M.
    Mehran, Roxana
    Granger, Christopher B.
    Parkhomenko, Alexander
    Bahit, M. Cecilia
    Windecker, Stephan
    Aronson, Ronald
    Berwanger, Otavio
    Halvorsen, Sigrun
    De Waha-Thiele, Suzanne
    Sinnaeve, Peter
    Darius, Harald
    Storey, Robert F.
    Lopes, Renato D.
    CIRCULATION, 2021, 143 (12) : 1215 - 1223
  • [30] Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome
    Alexander, John H.
    Lopes, Renato D.
    James, Stefan
    Kilaru, Rakhi
    He, Yaohua
    Mohan, Puneet
    Bhatt, Deepak L.
    Goodman, Shaun
    Verheugt, Freek W.
    Flather, Marcus
    Huber, Kurt
    Liaw, Danny
    Husted, Steen E.
    Lopez-Sendon, Jose
    De Caterina, Raffaele
    Jansky, Petr
    Darius, Harald
    Vinereanu, Dragos
    Cornel, Jan H.
    Cools, Frank
    Atar, Dan
    Luis Leiva-Pons, Jose
    Keltai, Matyas
    Ogawa, Hisao
    Pais, Prem
    Parkhomenko, Alexander
    Ruzyllo, Witold
    Diaz, Rafael
    White, Harvey
    Ruda, Mikhail
    Geraldes, Margarida
    Lawrence, Jack
    Harrington, Robert A.
    Wallentin, Lars
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (08): : 699 - 708
12345